143 related articles for article (PubMed ID: 8317409)
1. Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Komatsubara T; Matsuzawa Y; Okamoto M
Am J Gastroenterol; 1993 Jul; 88(7):1076-80. PubMed ID: 8317409
[TBL] [Abstract][Full Text] [Related]
2. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
[TBL] [Abstract][Full Text] [Related]
3. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of group II phospholipase A2 in intestine in Crohn's disease.
Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Nevalainen TJ
Am J Gastroenterol; 1999 Mar; 94(3):713-20. PubMed ID: 10086656
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease.
Minami T; Shinomura Y; Miyagawa J; Tojo H; Okamoto M; Matsuzawa Y
Am J Gastroenterol; 1997 Feb; 92(2):289-92. PubMed ID: 9040208
[TBL] [Abstract][Full Text] [Related]
6. Elevated group II phospholipase A2 mass concentration in serum and colonic mucosa in Crohn's disease.
Haapamäki MM; Grönroos JM; Nurmi H; Söderlund K; Peuravuori H; Alanen K; Nevalainen TJ
Clin Chem Lab Med; 1998 Oct; 36(10):751-5. PubMed ID: 9853800
[TBL] [Abstract][Full Text] [Related]
7. Correlation between serum phospholipase A(2) IIA levels and histological activity in patients with ulcerative colitis.
Yamaguchi O; Sugimura K; Ishizuka K; Suzuki K; Hasegawa K; Ohtsuka K; Honma T; Asakura H
Int J Colorectal Dis; 2002 Sep; 17(5):311-6. PubMed ID: 12172924
[TBL] [Abstract][Full Text] [Related]
8. Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.
Haapamäki MM; Grönroos JM; Nurmi H; Alanen K; Kallajoki M; Nevalainen TJ
Gut; 1997 Jan; 40(1):95-101. PubMed ID: 9155583
[TBL] [Abstract][Full Text] [Related]
9. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 gene expression and activity in histologically normal ileal mucosa and in Crohn's ileitis.
Lilja I; Smedh K; Olaison G; Sjödahl R; Tagesson C; Gustafson-Svärd C
Gut; 1995 Sep; 37(3):380-5. PubMed ID: 7590434
[TBL] [Abstract][Full Text] [Related]
11. Serum phospholipases A2 in patients undergoing panproctocolectomy because of severe ulcerative colitis.
Haapamäki MM; Grönroos JM; Pekkala E; Jokilammi-Siltanen A; Irjala K; Lertola K; Nevalainen TJ
Eur J Clin Chem Clin Biochem; 1997 Oct; 35(10):749-54. PubMed ID: 9368792
[TBL] [Abstract][Full Text] [Related]
12. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
Letizia C; D'Ambrosio C; Agostini D; Corsi A; Boirivant M; Pallone F; Scavo D
Ital J Gastroenterol; 1993 Jan; 25(1):23-5. PubMed ID: 8381313
[TBL] [Abstract][Full Text] [Related]
13. Phospholipase A2 in serum and colonic mucosa in ulcerative colitis.
Haapamäki MM; Grönroos JM; Nurmi H; Irjala K; Alanen KA; Nevalainen TJ
Scand J Clin Lab Invest; 1999 Jul; 59(4):279-87. PubMed ID: 10463466
[TBL] [Abstract][Full Text] [Related]
14. [Serum cholinesterases as activity parameters in chronic inflammatory bowel diseases].
Tromm A; Hüppe D; Thau I; Schwegler U; Kuntz HD; Krieg M; May B
Z Gastroenterol; 1992 Jul; 30(7):449-53. PubMed ID: 1380751
[TBL] [Abstract][Full Text] [Related]
15. Elevated serum anti-carbonic anhydrase II antibodies in patients with ulcerative colitis.
Andoh A; Fujiyama Y; Yoshioka U; Sasaki M; Araki Y; Tsujikawa T; Bamba T
Int J Mol Med; 2002 May; 9(5):499-502. PubMed ID: 11956656
[TBL] [Abstract][Full Text] [Related]
16. Serum lysozyme in Crohn's disease and ulcerative colitis.
Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
[TBL] [Abstract][Full Text] [Related]
17. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
18. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
[TBL] [Abstract][Full Text] [Related]
19. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation.
Matsui T; Yao T; Sakurai T; Yao K; Hirai F; Matake H; Tsuda S; Wada Y; Iwashita A; Kamachi S
J Gastroenterol; 2003; 38(7):647-55. PubMed ID: 12898357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
